Pilot intervention to enhance sexual rehabilitation for couples after treatment for localized prostate carcinoma

Cancer

Volumn 104, Issue 12, 2005, Pages 2689-2700

  Canada, Andrea L ^a   Neese, Leah E ^a   Sui, Dawen ^a   Schover, Leslie R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Counseling; Impotence; Prostatic neoplasms; Rehabilitation

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISTRESS SYNDROME; ERECTILE DYSFUNCTION; FEMALE; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MENTAL STRESS; OUTCOMES RESEARCH; PATIENT COUNSELING; PATIENT EDUCATION; PILOT STUDY; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SATISFACTION; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SURVIVAL TIME; UNITED STATES; CANCER LOCALIZATION; CANCER SURVIVOR; CLINICAL EFFECTIVENESS; CONFERENCE PAPER; INTERVENTION STUDY; PATIENT SATISFACTION; REHABILITATION CARE; SEX THERAPY; SEXUAL SATISFACTION;

AGED; CARCINOMA; COUPLES THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMPOTENCE; INTERVENTION STUDIES; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT EDUCATION; PATIENT SATISFACTION; PILOT PROJECTS; PROBABILITY; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIOTHERAPY, HIGH-ENERGY; RISK ASSESSMENT; SEX COUNSELING; TREATMENT OUTCOME;

EID: 29144495951     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21537     Document Type: Article

References (46)

1. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Classer DB, Rimm EB. Sexual function in men older than 50 years of age: results from the health professionals' follow-up study. Ann Intern Med. 2003;139:161-168.
2. Potosky AL, Davis WW, Hoffman RM, et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst. 2004;96:1358-1367.
3. Schover LR, Fouladi RT, Warneke CL, et al. Defining sexual outcomes after treatment for localized prostate carcinoma. Cancer. 2002;95:1773-1785.
4. Boberg EW, Gustafson DH, Hawkins RP, et al. Assessing the unmet information, support and care delivery needs of men with prostate cancer. Patient Educ Couns. 2003;49:233-242.
5. Davison BJ, Keyes M, Elliott S, Berkowitz J, Goldenberg SL. Preferences for sexual information resources in patients treated for early-stage prostate cancer with either radical prostatectomy or brachytherapy. BJU Int. 2004;93:965-969.
6. Rosen RC, Fisher WA, Eardley I, et al. The multinational Men's Attitudes to Life Events and Sexuality (MALES) study. I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin. 2004;20:607-617.
7. Shabsigh R, Perelman MA, Laumann EO, Lockhart DC. Drivers and barriers to seeking treatment for erectile dysfunction: a comparison of six countries. BJU Int. 2004;94:1055-1065.
8. Schover LR, Fouladi RT, Warneke CL, et al. The use of treatments for erectile dysfunction among survivors of prostate carcinoma. Cancer. 2002;95:2397-2407.
9. Gonzalgo ML, Brotzman M, Trock BJ, Geringer AM, Burnett AL, Jarow JP. Clinical efficacy of sildenafil citrate and predictors of long-term response. J Urol. 2003;170:503-506.
10. Stroberg P, Murphy A, Costigan T. Switching patients with erectile dysfunction from sildenafil citrate to tadalafil: results of a European multicenter, open-label study of patient preference. Clin Ther. 2003;25:2724-2737.
11. Koeman M, van Driel MF, Schultz WC, Mensink HJ. Orgasm after radical prostatectomy. Br J Urol. 1996;77:861-864.
12. Dahn JR, Penedo FJ, Gonzalez JS, et al. Sexual functioning and quality of life after prostate cancer treatment: considering sexual desire. Urology. 2004;63:273-277.
13. Barnas JL, Pierpaoli S, Ladd P, et al. The prevalence and nature of orgasmic dysfunction after radical prostatectomy. BJU Int. 2004;94:603-605.
14. Savoie M, Kim SS, Soloway MS. A prospective study measuring penile length in men treated with radical prostatectomy for prostate cancer. J Urol. 2003;169:1462-1464.
15. Latini DM, Penson DF, Lubeck DP, Wallace KL, Henning JM, Lue TF. Longitudinal differences in disease specific quality of life in men with erectile dysfunction: results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction study. J Urol. 2003;169:1437-1442.
16. Tomlinson J, Wright D. Impact of erectile dysfunction and its subsequent treatment with sildenafil: qualitative study. BMJ. 2004;328:1037. Epub 2004 Mar 29.
17. Schover LR, Fouladi RT, Warneke CL, et al. Seeking help for erectile dysfunction after treatment for prostate cancer. Arch Sex Behav. 2004;33:443-454.
18. Manne S, Babb J, Pinover W, Horwitz E, Ebbert J. Psychoeducational group intervention for wives of men with prostate cancer. Psychooncology. 2004;13:37-46.
19. Mishel MH, Belyea M, Germino BB, et al. Helping patients with localized prostate carcinoma manage uncertainty and treatment side effects: nurse-delivered psychoeducational intervention over the telephone. Cancer. 2002;94:1854-1866.
20. Weber BA, Roberts BL, Resnick M, et al. The effect of dyadic intervention on self-efficacy, social support, and depression for men with prostate cancer. Psychooncology. 2004;13:47-60.
21. Neese LE, Schover LR, Klein EA, Zippe C, Kupelian PA. Finding help for sexual problems after prostate cancer treatment: a phone survey of men's and women's perspectives. Psychooncology. 2003;12:463-473.
22. Schover L. Sexual problems in chronic illness, 3rd ed. New York: Guilford, 2000.
23. Taves DR. Minimization: a new method of assigning patients to treatment and control groups. Clin Pharmacol Ther. 1974;15:443-453.
24. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics. 1975;31:103-115.
25. Rovers MM, Straatman H, Zielhuis GA. Comparison of balanced and random allocation in clinical trials: a simulation study. Eur J Epidemiol. 2000;16:1123-1129.
26. Pocock SJ. Clinical trials: a practical approach. New York: John Wiley & Sons, 1993.
27. Rosen RC, Riley A, Wagner G, et al. The International Index of Erectile Function (IIEF): a multidimensional scale for the assessment of erectile dysfunction. Urology. 1997;49:822-830.
28. Rosen RC, Cappelleri JC, Gendrano N 3rd. The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res. 2002;14:226-244.
29. Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191-208.
30. Meston CM, Validation of the Female Sexual Function Index (FSFI) in women with female orgasmic disorder and in women with hypoactive sexual desire disorder. J Sex Marital Ther. 2003;29:39-46.
31. Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med. 1983;13:595-605.
32. Sharpley C, Cross D. A psychometric evaluation of the Spanier Dyadic Adjustment Scale. J Marriage Fam. 1982;44:739-741.
33. Carey M, Specter IP, Lantinga LJ, Krauss DJ. Reliability of the Dyadic Adjustment Scale. Psychol Assess. 1993;5:238-240.
34. Hunsley J, Pinsent C, Lefebre M, James-Tanner S, Vito D. Construct validity of the short forms of the Dyadic Adjustment Scale. Fam Relat. 1993;44:231-237.
35. Hunsley J, Best M, Lefebre M. The Dyadic Adjustment Scale short form: establishing a marital distress cut-off score. 33rd Annu Conv AABT. 1999.
36. Lubeck DP, Litwin MS, Henning JM, Carroll PR. Measurement of health-related quality of life in men with prostate cancer: the CaPSURE database. Qual Life Res. 1997;6:385-392.
37. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care. 1998;36:1002-1012.
38. Day R, Ganz PA, Costantino JP, Cronin WM, Wickerham DL, Fisher B. Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Clin Oncol. 1999;17:2659-2669.
39. Ganz PA, Greendale GA, Petersen L, Zibecchi L, Kahn B, Belin TR. Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. J Natl Cancer Inst. 2000;92:1054-1064.
40. Ware JE. SF-36 Health Survey: manual and interpretation guide. Boston: Health Institute, 1993.
41. Ware JE, Kosinski M. Interpreting SF-36 summary health measures: a response. Qual Life Res. 2001;10:405-413; discussion 415-420.
42. Bokhour BG, Clark JA, Inui TS, Silliman RA, Talcott JA. Sexuality after treatment for early prostate cancer: exploring the meanings of "erectile dysfunction". J Gen Intern Med. 2001;16:649-655.
43. Laken V, Laken K. Making love again: hope for couples facing loss of sexual intimacy. Sandwich, MA: Ant Hill Press, 2002.
44. Schover L, Leiblum S. Commentary: the stagnation of sex therapy. J Psychol Hum Sex. 1994;6:5-30.
45. Jenkins R, Schover LR, Fouladi RT, et al. Sexuality and health-related quality of life after prostate cancer in African-American and white men treated for localized disease. J Sex Marital Ther. 2004;30:79-93.
46. Johnson TK, Gilliland FD, Hoffman RM, et al. Racial/ethnic differences in functional outcomes in the 5 years after diagnosis of localized prostate cancer. J Clin Oncol. 2004;22:4193-4201.